28
May

As promised, Valeant Pharmaceuticals has returned to the deal table with a sweetened pitch for Allergan, putting up a bigger offer with more cash and even making an uncharacteristic commitment to R&D.

…read more

Source: Valeant dials up its Allergan bid and throws in some R&D promises

    

0 No comments